Norah Terrault, MD, MPH

Professor of Medicine, Chief, Division of GI and Liver: Neil Kaplowitz Chair in Liver Diseases

Image of Norah Terrault, MD, MPH
Is this your profile? Click to edit

Overview

Dr. Norah Terrault is Professor of Medicine and Chief of Gastroenterology and Liver Diseases and Neil Kaplowitz Endowed Chair in Liver Diseases Research. She received her MD from the University of Alberta and completed fellowships in Internal Medicine and Gastroenterology at the University of Toronto and a Masters in Public Health at the University of California at Berkeley. Dr. Terrault has focused her clinical and research activities on viral hepatitis and steatotic liver disease (metabolic and alcohol-associated), especially in special populations including those with cirrhosis and those with transplants. In addition to multiple clinical trials related to preventing and treating chronic hepatitis viral hepatitis and metabolic steatotic liver disease, Dr. Terrault has been PI on multiple NIH-funded studies, including the current NIDDK-supported Liver Cirrhosis Network and nonalcoholic steatohepatitis clinical research network (NASH CRN). She has authored more than 450 peer-reviewed manuscripts, editorials, and invited reviews as well as co-authoring US national guidelines for treatment of chronic hepatitis B and C and alcohol-associated liver disease. She is past associate editor for Hepatology and deputy editor for Liver Transplantation and co-edited Zakim and Boyer’s textbook in hepatology. Dr. Terrault is currently serving as the president of the American Association for the Study of Liver Diseases (AASLD). She is the founder of USC Project ECHO, a multifaceted program to train and support primary care physicians in California to care for patients with viral hepatitis. She has a long history of mentoring fellows and junior faculty in clinical research and is passionate about creating research support and opportunities for the next generation of GI/Hepatology investigators.

Publications

  • Reply: Recognizing the new nomenclature requires a comprehensive analysis of the prevalence, severity, and long-term outlook for SLD and subclassifications Hepatology. 2024 Apr 01; 79(4):E117-E118. . View in PubMed
  • Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET study Am J Transplant. 2024 Mar; 24(3):468-478. . View in PubMed
  • National prevalence estimates for steatotic liver disease and subclassifications using consensus nomenclature Hepatology. 2024 Mar 01; 79(3):666-673. . View in PubMed
  • Maternal neighbourhood-level social determinants of health and their association with paediatric hepatitis C screening among children exposed to hepatitis C in pregnancy Paediatr Perinat Epidemiol. 2024 Feb; 38(2):152-160. . View in PubMed
  • A global action agenda for turning the tide on fatty liver disease Hepatology. 2024 Feb 01; 79(2):502-523. . View in PubMed
  • Antimullerian Hormone, a Marker of Ovarian Reserve, Is Protective Against Presence and Severity of NASH in Premenopausal WomenClin Gastroenterol Hepatol. 2024 02; 22(2):339-346. e5. . View in PubMed
  • Prevalence, Risk Profiles, and National Implications of Nonalcoholic Fatty Liver Disease in Pregnant IndividualsClin Gastroenterol Hepatol. 2024 01; 22(1):194-196. e1. . View in PubMed
  • Peginterferon as Part of a Functional Cure Strategy for Hepatitis B: Is the Juice Worth the Squeeze? J Clin Exp Hepatol. 2024 Jan-Feb; 14(1):101300.. View in PubMed
  • Country-Specific Screening, Prevalence, and Immunity Rates for Hepatitis B Infection in a Large US Safety-Net System Open Forum Infect Dis. 2024 Jan; 11(1):ofad699. . View in PubMed
  • Low frequency of HBsAg reemergence in liver transplant recipients after stopping hepatitis B immune globulin: Implications for prophylaxis protocols Liver Transpl. 2023 Dec 12. . View in PubMed
  • Neighborhood-level Social Determinants of Health and Waitlist Mortality for Liver Transplantation: The Liver Outcomes and Equity Index Transplantation. 2023 Dec 05. . View in PubMed
  • Down-Classification of Hepatitis C Virus Diagnostics: Implications for Screening and Diagnosis J Infect Dis. 2023 Sep 22. . View in PubMed
  • Hepatitis B RNA and Core-Related Antigen Provide Value Beyond DNA in Evaluating e But Not Surface Antigen Clearance Clin Gastroenterol Hepatol. 2023 Jul; 21(7):1957-1959. . View in PubMed
  • Global importance of new treatment strategies to efforts to control hepatitis B virus Expert Rev Anti Infect Ther. 2023 Jul-Dec; 21(8):847-862. . View in PubMed
  • Quantifying the Negative Impact of Fast-food Consumption on Liver Steatosis Among United States Adults With Diabetes and ObesityClin Gastroenterol Hepatol. 2023 11; 21(12):3176-3178. e3. . View in PubMed
  • Liver transplantation for alcohol-associated liver disease: A call for national standards of best practices to monitor and bridge disparities in access and outcomes Am J Transplant. 2023 08; 23(8):1097-1101. . View in PubMed
  • Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries J Hepatol. 2023 08; 79(2):576-580. . View in PubMed
  • Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter StudyGastroenterology. 2023 08; 165(2):463-472. e5. . View in PubMed
  • Healthcare affordability and effects on mortality among adults with liver disease from 2004 to 2018 in the United States J Hepatol. 2023 08; 79(2):329-339. . View in PubMed
  • Liver Transplantation 2023: Status Report, Current and Future Challenges Clin Gastroenterol Hepatol. 2023 07; 21(8):2150-2166. . View in PubMed
  • Population-attributable risk of modifiable lifestyle factors to hepatocellular carcinoma: The multi-ethnic cohort Aliment Pharmacol Ther. 2023 07; 58(1):89-98. . View in PubMed
  • Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus InfectionClin Gastroenterol Hepatol. 2023 06; 21(6):1503-1512. e4. . View in PubMed
  • Geographic Density of Gastroenterologists Is Associated With Decreased Mortality From Alcohol-Associated Liver DiseaseClin Gastroenterol Hepatol. 2023 06; 21(6):1542-1551. e6. . View in PubMed
  • National Trends in Alcohol Use, Metabolic Syndrome, and Liver Disease From 1999 to 2018 Ann Intern Med. 2023 06; 176(6):879-882. . View in PubMed
  • Global epidemiology of cirrhosis – aetiology, trends and predictions Nat Rev Gastroenterol Hepatol. 2023 06; 20(6):388-398. . View in PubMed
  • The scientific basis of combination therapy for chronic hepatitis B functional cure Nat Rev Gastroenterol Hepatol. 2023 04; 20(4):238-253. . View in PubMed
  • Liver transplant for alcohol-associated liver disease continues to rise 2 years into the COVID-19 pandemic especially among young adults J Hepatol. 2023 04; 78(4):e139-e141. . View in PubMed
  • Addressing sex-based disparities in solid organ transplantation in the United States – a conference report Am J Transplant. 2023 03; 23(3):316-325. . View in PubMed
  • Health disparities in chronic liver disease Hepatology. 2023 04 01; 77(4):1382-1403. . View in PubMed
  • Universal Adult Hepatitis B Screening and Vaccination as the Path to Elimination JAMA. 2023 05 16; 329(19):1639-1640. . View in PubMed
  • Disparities in presentation and management of chronic hepatitis B among Hispanics in a diverse safety net system Hepatol Commun. 2023 04 01; 7(4). . View in PubMed
  • Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B Am J Gastroenterol. 2023 07 01; 118(7):1214-1225. . View in PubMed
  • Reproductive health and liver disease: a patient-friendly summary of the 2021 AASLD guidance Clin Liver Dis (Hoboken). 2023 Jan; 21(1):19-35. . View in PubMed
  • Association of nativity with survival among adults with hepatocellular carcinoma J Natl Cancer Inst. 2023 07 06; 115(7):861-869. . View in PubMed
  • Association of Alanine Aminotransferase Flares to Hepatitis B Surface Decline During Tenofovir Alone or With Pegylated Interferon Alfa Am J Gastroenterol. 2023 11 01; 118(11):2075-2079. . View in PubMed
  • Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial Am J Gastroenterol. 2023 07 01; 118(7):1226-1236. . View in PubMed
  • Multicentered study of patient outcomes after declined for early liver transplantation in severe alcohol-associated hepatitis Hepatology. 2023 04 01; 77(4):1253-1262. . View in PubMed
  • Use of HBV RNA and to predict change in serological status and disease activity in CHB Hepatology. 2023 11 01; 78(5):1542-1557. . View in PubMed
  • Food Insecurity is Associated With Mortality Among US. Adults With Nonalcoholic Fatty Liver Disease and Advanced Fibrosis. Clin Gastroenterol Hepatol. 2022 Dec; 20(12):2790-2799. e4. . View in PubMed
  • Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease Hepatol Commun. 2022 Dec; 6(12):3433-3442. . View in PubMed
  • Racial and ethnic differences in diet quality and food insecurity among adults with fatty liver and significant fibrosis: a US. population-based study. Aliment Pharmacol Ther. 2022 Nov; 56(9):1383-1393. . View in PubMed
  • In Memoriam-Hugo RRosen. Gastroenterology. 2022 Nov; 163(5):1135-1136. . View in PubMed
  • Reply Gastroenterology. 2022 Sep 29. . View in PubMed
  • Geographic hotspot detection for late-stage hepatocellular carcinoma: novel approach to cancer control Cancer Causes Control. 2022 May; 33(5):701-710. . View in PubMed
  • Optimizing Hepatology Education in the Virtual World Clin Liver Dis (Hoboken). 2022 Apr; 19(4):139-143. . View in PubMed
  • Hepatic macrosteatosis in the US pediatric deceased liver donor population Pediatr Transplant. 2022 Feb; 26(1):e14155. . View in PubMed
  • Hepatitis B virus reactivation associated with new classes of immunosuppressants and immunomodulators: A systematic review, meta-analysis, and expert opinion J Hepatol. 2022 12; 77(6):1670-1689. . View in PubMed
  • Influence of hepatitis C viral parameters on pregnancy complications and risk of mother-to-child transmission J Hepatol. 2022 11; 77(5):1256-1264. . View in PubMed
  • Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts J Gen Intern Med. 2022 10; 37(13):3435-3443. . View in PubMed
  • Advocacy for Equity in Transplantation Access for Alcohol-Associated Liver Disease: How Research Changed Medi-Cal Policy Gastroenterology. 2022 09; 163(3):539-542. . View in PubMed
  • Letter: non-invasive prediction models to exclude cirrhosis in NAFLD-not everyone fits the mouldAuthors’ reply. Aliment Pharmacol Ther. 2022 07; 56(1):182-183. . View in PubMed
  • Metabolic Risk Profiles for Hepatic Steatosis Differ by Race/Ethnicity: An Elastography-Based Study of US Adults Dig Dis Sci. 2022 07; 67(7):3340-3355. . View in PubMed
  • Pregnancy-Associated Liver DiseasesGastroenterology. 2022 07; 163(1):97-117. e1. . View in PubMed
  • Artificial intelligence to identify harmful alcohol use after early liver transplant for alcohol-associated hepatitis Am J Transplant. 2022 07; 22(7):1834-1841. . View in PubMed
  • Alcohol use trajectories among US. adults during the first 42 weeks of the COVID-19 pandemic. Alcohol Clin Exp Res. 2022 06; 46(6):1062-1072. . View in PubMed
  • Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD) Aliment Pharmacol Ther. 2022 06; 55(11):1441-1451. . View in PubMed
  • Breakthroughs in hepatology J Hepatol. 2022 06; 76(6):1247-1248. . View in PubMed
  • Diverging Incidence Trends for Hepatocellular Carcinoma in Rural and Urban Settings in the United StatesClin Gastroenterol Hepatol. 2022 05; 20(5):1180-1185. e2. . View in PubMed
  • Discordance in categorization of acute-on-chronic liver failure in the United Network for Organ Sharing database J Hepatol. 2022 05; 76(5):1122-1126. . View in PubMed
  • Aiming for Functional Cure With Established and Novel Therapies for Chronic Hepatitis B Hepatol Commun. 2022 05; 6(5):935-949. . View in PubMed
  • Reply Hepatology. 2022 03; 75(3):761-763. . View in PubMed
  • Incidence and prediction of HBsAg seroclearance in a prospective multi-ethnic HBeAg-negative chronic hepatitis B cohort Hepatology. 2022 03; 75(3):709-723. . View in PubMed
  • Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic HepatitisClin Gastroenterol Hepatol. 2022 02; 20(2):409-418. e5. . View in PubMed
  • Medicaid expansion and variability in mortality in the USA: a national, observational cohort study Lancet Public Health. 2022 01; 7(1):e48-e55. . View in PubMed
  • Portrait of Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis in the United States Am J Gastroenterol. 2022 03 01; 117(3):433-444. . View in PubMed
  • Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms PLoS One. 2022; 17(4):e0266859. . View in PubMed
  • Changes and mediators of survival disparity among Black liver transplant recipients in the United States Am J Transplant. 2021 12; 21(12):3883-3893. . View in PubMed
  • Use of Hepatitis B Virus-Positive Organs in Organ Transplantation Clin Liver Dis. 2021 11; 25(4):841-857. . View in PubMed
  • Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America Hepatology. 2021 11; 74(5):2395-2409. . View in PubMed
  • Enhanced Screening for Hepatitis D in the USA: Overcoming the Delta Blues Dig Dis Sci. 2021 08; 66(8):2483-2485. . View in PubMed
  • Retail Alcohol and Tobacco Sales During COVID-19 Ann Intern Med. 2021 07; 174(7):1027-1029. . View in PubMed
  • Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantation J Hepatol. 2021 07; 75 Suppl 1:S178-S190. . View in PubMed
  • Testosterone is Associated With Nonalcoholic Steatohepatitis and Fibrosis in Premenopausal Women With NAFLDClin Gastroenterol Hepatol. 2021 06; 19(6):1267-1274. e1. . View in PubMed
  • Prospective Multicenter Study of Early Antiviral Therapy in Liver and Kidney Transplant Recipients of HCV-Viremic Donors Hepatology. 2021 06; 73(6):2110-2123. . View in PubMed
  • Associations Between Reproductive and Hormone-Related Factors and Risk of Nonalcoholic Fatty Liver Disease in a Multiethnic PopulationClin Gastroenterol Hepatol. 2021 06; 19(6):1258-1266. e1. . View in PubMed
  • Reply to ‘Evidence against in utero transmission of hepatitis B virus’ Nat Rev Gastroenterol Hepatol. 2021 06; 18(6):445-446. . View in PubMed
  • Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality J Hepatol. 2021 06; 74(6):1355-1361. . View in PubMed
  • Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy Hepatology. 2021 06; 73(6):2124-2140. . View in PubMed
  • Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplant Am J Transplant. 2021 05; 21(5):1780-1788. . View in PubMed
  • Adherence to pregnancy hepatitis B care guidelines in women and infants in the United States and evaluation of two interventions to improve care: A multicentre hospital-based study J Viral Hepat. 2021 04; 28(4):582-591. . View in PubMed
  • Caesarean section or non-breastfeeding for prevention of MTCT-beware of sending the wrong message J Viral Hepat. 2021 03; 28(3):575-576. . View in PubMed
  • The Internet as a Tool for Liver Transplant Programs to Combat Stigma Related to Alcohol Use Disorder Hepatol Commun. 2021 02; 5(2):155-157. . View in PubMed
  • Viral hepatitis and pregnancy Nat Rev Gastroenterol Hepatol. 2021 02; 18(2):117-130. . View in PubMed
  • Addressing Social Determinants of Liver Disease During the COVID-19 Pandemic and Beyond: A Call to Action Hepatology. 2021 02; 73(2):811-820. . View in PubMed
  • Low Testosterone Is Associated With Nonalcoholic Steatohepatitis and Fibrosis Severity in MenClin Gastroenterol Hepatol. 2021 02; 19(2):400-402. e2. . View in PubMed
  • Presentation, Management, and Outcomes Across the Rural-Urban Continuum for Hepatocellular Carcinoma JNCI Cancer Spectr. 2021 02; 5(1). . View in PubMed
  • Excess Mortality After Liver Transplantation in Young Women With Alcohol-Associated Liver Disease Am J Gastroenterol. 2021 03 01; 116(3):551-559. . View in PubMed
  • Transplanting Kidneys From Donors With Chronic Hepatitis B: Bringing Transmission Risk Closer to Zero Clin Infect Dis. 2021 03 15; 72(6):1024-1025. . View in PubMed
  • Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease Semin Thromb Hemost. 2020 Sep; 46(6):682-692. . View in PubMed
  • Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America Ann Hepatol. 2020 Jul – Aug; 19(4):437-445. . View in PubMed
  • Maternal knowledge of the risk of vertical transmission and offspring acquisition of hepatitis B Ann Hepatol. 2020 Jul – Aug; 19(4):388-395. . View in PubMed
  • Selective use of liver transplantation for severe alcohol-associated hepatitis Expert Rev Gastroenterol Hepatol. 2020 Mar; 14(3):175-184. . View in PubMed
  • Outcomes of Pregnant Women With Cirrhosis and Their Infants in a Population-Based StudyGastroenterology. 2020 11; 159(5):1752-1762. e10. . View in PubMed
  • The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transplantation: An International Multicenter Study Transplantation. 2020 10; 104(10):2087-2096. . View in PubMed
  • Temporal Trends and Outcomes in Liver Transplantation for Recipients With HIV Infection in Europe and United States Transplantation. 2020 10; 104(10):2078-2086. . View in PubMed
  • Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes J Hepatol. 2020 09; 73(3):516-522. . View in PubMed
  • DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort J Hepatol. 2020 09; 73(3):540-548. . View in PubMed
  • Letter to the Editor: Safety First: Favoring Prophylactic/Preemptive Over Delayed Treatment in D+/R- Transplants Hepatology. 2020 08; 72(2):787. . View in PubMed
  • Mortality in adults with chronic hepatitis B infection in the United States: a population-based study Aliment Pharmacol Ther. 2020 07; 52(2):382-389. . View in PubMed
  • Medicaid Policy and Liver Transplant for Alcohol-Associated Liver Disease Hepatology. 2020 07; 72(1):130-139. . View in PubMed
  • KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Am J Kidney Dis. 2020 05; 75(5):665-683. . View in PubMed
  • Guidance for design and endpoints of clinical trials in chronic hepatitis B – Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡ J Hepatol. 2020 03; 72(3):539-557. . View in PubMed
  • Liver and Kidney Recipient Selection of Hepatitis C Virus Viremic Donors: Meeting Consensus Report From the 2019 Controversies in Transplantation Transplantation. 2020 03; 104(3):476-481. . View in PubMed
  • Expanding the use of hepatitis C-positive donors and keeping recipient safety at the forefront Am J Transplant. 2020 03; 20(3):627-628. . View in PubMed
  • Liver transplantation as therapy for hepatocellular carcinoma Liver Int. 2020 02; 40 Suppl 1:116-121. . View in PubMed
  • Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis Liver Int. 2020 02; 40(2):355-359. . View in PubMed
  • Gaps in Viral Hepatitis Awareness in the United States in a Population-based StudyClin Gastroenterol Hepatol. 2020 01; 18(1):188-195. e4. . View in PubMed
  • HBV Genotype-Specific Levels of Hepatitis B Surface Antigen Improve HBV Phenotype Definition Clin Gastroenterol Hepatol. 2020 01; 18(1):259-261. . View in PubMed
  • Trends in Hepatitis B Infection and Immunity Among Women of Childbearing Age in the United States Clin Infect Dis. 2020 07 27; 71(3):586-592. . View in PubMed
  • Oncogenic HBV variants and integration are present in hepatic and lymphoid cells derived from chronic HBV patients Cancer Lett. 2020 06 28; 480:39-47. . View in PubMed
  • Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update J Clin Oncol. 2020 11 01; 38(31):3698-3715. . View in PubMed
  • Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV InfectionClin Gastroenterol Hepatol. 2019 11; 17(12):2541-2551. e2. . View in PubMed
  • Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia Am J Gastroenterol. 2019 11; 114(11):1753-1763. . View in PubMed
  • Intentional Transmission of Hepatitis C With Organ Transplantation: With Opportunity Comes Responsibility Transplantation. 2019 11; 103(11):2215-2216. . View in PubMed
  • Superior Wait-List Outcomes in Patients with Alcohol-Associated Liver Disease Compared With Other Indications for Liver Transplantation Liver Transpl. 2019 09; 25(9):1310-1320. . View in PubMed
  • Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated HepatitisGastroenterology. 2019 08; 157(2):472-480. e5. . View in PubMed
  • Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study Am J Gastroenterol. 2019 08; 114(8):1283-1291. . View in PubMed
  • Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B J Viral Hepat. 2019 07; 26(7):856-865. . View in PubMed
  • Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection Hepatology. 2019 06; 69(6):2338-2348. . View in PubMed
  • Relationship between three commonly used non-invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non-alcoholic steatohepatitis Liver Int. 2019 05; 39(5):924-932. . View in PubMed
  • Outcomes of Sleeve Gastrectomy in Obese Liver Transplant Candidates Liver Transpl. 2019 04; 25(4):538-544. . View in PubMed
  • Cost Effectiveness of Transplanting HCV-Infected Livers Into Uninfected Recipients With Preemptive Antiviral TherapyClin Gastroenterol Hepatol. 2019 03; 17(4):739-747. e8. . View in PubMed
  • Reply Gastroenterology. 2019 02; 156(3):825-826. . View in PubMed
  • Viral Hepatitis and Hepatocellular Carcinoma Gastroenterology. 2019 01; 156(2):293. . View in PubMed
  • Reply Gastroenterology. 2019 01; 156(1):286-287. . View in PubMed
  • Factors Associated With Histologic Response in Adult Patients With Nonalcoholic SteatohepatitisGastroenterology. 2019 01; 156(1):88-95. e5. . View in PubMed
  • Longer lactation duration is associated with decreased prevalence of non-alcoholic fatty liver disease in women J Hepatol. 2019 01; 70(1):126-132. . View in PubMed
  • Use of hepatitis C viraemic organs in kidney transplantation: a need to hit the pause button? Nat Rev Gastroenterol Hepatol. 2019 01; 16(1):5-6.. View in PubMed
  • New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Virus InfectionGastroenterology. 2019 01; 156(2):355-368. e3. . View in PubMed
  • National Trends and Long-term Outcomes of Liver Transplant for Alcohol-Associated Liver Disease in the United States JAMA Intern Med. 2019 03 01; 179(3):340-348. . View in PubMed
  • Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease JAMA Netw Open. 2019 10 02; 2(10):e1912565. . View in PubMed
  • Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient Transpl Infect Dis. 2018 Feb; 20(1). . View in PubMed
  • Is Low Level Viremia Acceptable During Antiviral Therapy of Patients With HBV Infection and Decompensated Cirrhosis? Clin Gastroenterol Hepatol. 2018 12; 16(12):1876-1878.. View in PubMed
  • Hepatitis C in Patients With RenalDisease: A Deeper Dive Into the KDIGO Guideline Hepatology. 2018 11; 68(5):2035-2038. . View in PubMed
  • Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and CirrhosisClin Gastroenterol Hepatol. 2018 11; 16(11):1811-1819. e4. . View in PubMed
  • A changing landscape of liver transplantation: King HCV is dethroned, ALD and NAFLD take over! J Hepatol 2018 10; 69(4):767-768. . View in PubMed
  • Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy Am J Transplant. 2018 10; 18(10):2506-2512. . View in PubMed
  • Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia Gastroenterology. 2018 09; 155(3):705-718. . View in PubMed
  • Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and SteatohepatitisClin Gastroenterol Hepatol. 2018 09; 16(9):1511-1520. e5. . View in PubMed
  • Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic HepatitisGastroenterology. 2018 08; 155(2):422-430. e1. . View in PubMed
  • Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout Hepatology. 2018 08; 68(2):449-461. . View in PubMed
  • Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus InfectionGastroenterology. 2018 06; 154(8):2111-2121. e8. . View in PubMed
  • Tenofovir to Prevent Perinatal Transmission of Hepatitis B N Engl J Med. 2018 06 14; 378(24):2348-9. . View in PubMed
  • Management of hepatitis B in special populations Best Pract Res Clin Gastroenterol. 2017 Jun; 31(3):311-320. . View in PubMed
  • Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant Ann Hepatol. 2017 May – Jun; 16(3):375-381. . View in PubMed
  • Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver DiseaseGastroenterology. 2017 11; 153(5):1260-1272. e3. . View in PubMed
  • Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients Transplantation. 2017 09; 101(9):2079-2082. . View in PubMed
  • Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review. Hepatology. 2017 06; 65(6):2090-2099.. View in PubMed
  • International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates Transplantation. 2017 05; 101(5):945-955. . View in PubMed
  • International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients Transplantation. 2017 05; 101(5):956-967. . View in PubMed
  • Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy Hepatology. 2017 03; 65(3):804-812. . View in PubMed
  • Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic SteatohepatitisClin Gastroenterol Hepatol. 2017 01; 15(1):127-131. e2. . View in PubMed
  •  Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant Ann Hepatol. 2016 Jul-Aug; 15(4):545-9. . View in PubMed
  • Emerging Therapies for Nonalcoholic Fatty Liver Disease Clin Liver Dis. 2016 May; 20(2):365-85. . View in PubMed
  • Report from the International Conference on Viral Hepatitis (ICVH), San Francisco, March 2016 AIDS Rev. 2016 Apr-Jun; 18(2):81-8. . View in PubMed
  • Perspectives on treating hepatitis C infection in the liver transplantation setting Curr Opin Organ Transplant. 2016 Apr; 21(2):111-9. . View in PubMed
  • Response to clinical assessments of health status as a potential marker to identify patients who are too sick to undergo transplantation Liver Int. 2016 Apr; 36(4):611. . View in PubMed
  • Hepatitis B Virus–Specific and Global T-Cell Dysfunction in Chronic Hepatitis BGastroenterology. 2016 Mar; 150(3):684-695. e5. . View in PubMed
  • Liver transplant recipients and prioritization of anti-HCV therapy: an Italian cohort analysis Liver Int. 2016 Mar; 36(3):410-7. . View in PubMed
  • Optimizing the pre-referral workup for gastroenterology and hepatology specialty care: consensus using the Delphi method J Eval Clin Pract. 2016 Feb; 22(1):46-52. . View in PubMed
  • Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic ResponseGastroenterology. 2016 12; 151(6):1131-1140. e5. . View in PubMed
  • Real-World Experiences with Tenofovir Disoproxil Fumarate: Is this the “B-Ticket”? Dig Dis Sci. 2016 10; 61(10):2770-2772.. View in PubMed
  • Management of the patient with SVR J Hepatol. 2016 10; 65(1 Suppl):S120-S129. . View in PubMed
  • Hepatitis B surface antigen loss: Not all that we hoped it would be Hepatology. 2016 08; 64(2):328-9. . View in PubMed
  • Women with Cirrhosis: Prevalence, Natural History, and Management Gastroenterol Clin North Am. 2016 06; 45(2):345-58. . View in PubMed
  • Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network Liver Transpl. 2016 Jan; 22(1):24-33. . View in PubMed
  • Facility- and Patient-Level Factors Associated with Esophageal Variceal Screening in the USA Dig Dis Sci. 2016 Jan; 61(1):62-9. . View in PubMed
  • Diabetes and prediabetes in patients with hepatitis B residing in North America Hepatology. 2015 Nov; 62(5):1364-74. . View in PubMed
  • Severe Cholestatic Hepatitis C in Transplant Recipients: No Longer a Threat to Graft Survival Clin Gastroenterol Hepatol. 2015 Nov; 13(11):2002-4. . View in PubMed
  • Current Management of Hepatitis C Virus: Regimens for Peri-Liver Transplant Patients Clin Liver Dis. 2015 Nov; 19(4):669-88vi. . View in PubMed
  • Clinician assessments of health status predict mortality in patients with end-stage liver disease awaiting liver transplantation Liver Int. 2015 Sep; 35(9):2167-73. . View in PubMed
  • Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease Gastroenterology. 2015 Sep; 149(3):649-59. . View in PubMed
  • New Therapies, Evidence, and Guidance in Hepatitis C Management: Expert Practices and Insights from an Educational Symposium at the AMCP 27th Annual Meeting Expo J Manag Care Spec Pharm. 2015 Sep; 21(9):S1-14. . View in PubMed
  • Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C-Infected Patients With Compensated and Decompensated Cirrhosis Hepatology. 2015 Sep; 62(3):715-25. . View in PubMed
  • The corrected donor age for hepatitis C virus-infected liver transplant recipients Liver Transpl. 2015 Aug; 21(8):1022-30. . View in PubMed
  • Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study Transplantation. 2015 Aug; 99(8):1644-51. . View in PubMed
  • High Rate of Hospital Admissions Among Patients with Cirrhosis Seeking Care in US Emergency Departments Dig Dis Sci. 2015 Jul; 60(7):2183-9. . View in PubMed
  • Bone Mineral Density, Bone Turnover, and Systemic Inflammation in Non-cirrhotics with Chronic Hepatitis C Dig Dis Sci. 2015 Jun; 60(6):1813-9. . View in PubMed
  • Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos in Liver Transpl. 2015 Apr; 21(4):423-34. . View in PubMed
  • Outcomes in liver transplantation: does sex matter? J Hepatol. 2015 Apr; 62(4):946-55.. View in PubMed
  • Hepatitis C direct antiviral drugs and hepatic decompensation in patients with advanced cirrhosis: culprit or innocent bystander? Dig Dis Sci. 2015 Apr; 60(4):806-9.. View in PubMed
  • Reply to Prediction of hepatocellular carcinoma: using a complex risk model or assisting for smoking cessation? Cancer. 2015 Apr 01; 121(7):1150.. View in PubMed
  • Hepatitis C genotype influences post-liver transplant outcomes Transplantation. 2015 Apr; 99(4):835-40. . View in PubMed
  • Reply: To PMID 25045002 Liver Transpl. 2015 Mar; 21(3):416. . View in PubMed
  • Outcome and management of HCV/HIV coinfection pre- and post-liver transplantationA 2015 update. J Hepatol. 2015 Mar; 62(3):701-11. . View in PubMed
  • Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients Liver Transpl. 2015 Feb; 21(2):272-4. . View in PubMed
  • Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation Gastroenterology. 2015 Jan; 148(1):108-17. . View in PubMed
  • Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype Clin Gastroenterol Hepatol. 2015 Jan; 13(1):183-92. . View in PubMed
  • Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label studyGastroenterology. 2015 Jan; 148(1):100-107. e1. . View in PubMed
  • An interferon-free antiviral regimen for HCV after liver transplantation N Engl J Med. 2014 Dec 18; 371(25):2375-82. . View in PubMed
  • Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure J Hepatol. 2014 Dec; 61(6):1253-9. . View in PubMed
  • Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model Cancer. 2014 Nov 15; 120(22):3485-93. . View in PubMed
  • Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization Liver Transpl. 2014 Oct; 20(10):1221-8. . View in PubMed
  • A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy J Hepatol. 2014 Sep; 61(3):508-14. . View in PubMed
  • Characteristics and management of patients with chronic hepatitis B in an integrated care setting Dig Dis Sci. 2014 Sep; 59(9):2100-8. . View in PubMed
  • Ending vertical transmission of hepatitis B: the third trimester intervention Hepatology. 2014 Aug; 60(2):448-51. . View in PubMed
  • Randomized controlled trial of danoprevir plus peginterferon alfa-2a and ribavirin in treatment-naïve patients with hepatitis C virus genotype 1 infectionGastroenterology. 2013 Oct; 145(4):790-800. e3. . View in PubMed
  • Solid organ transplants in HIV-infected patients Curr HIV/AIDS Rep. 2013 Sep; 10(3):217-25. . View in PubMed
  • A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation Hepatology. 2013 May; 57(5):1752-62. . View in PubMed
  • Acute hepatitis C in an HIV-infected patient: a case report and review of literature J Gen Intern Med. 2013 May; 28(5):734-8. . View in PubMed
  • Approach to the treatment-experienced patient with hepatitis C virus genotype 1 infection Infect Dis Clin North Am. 2012 Dec; 26(4):903-15. . View in PubMed
  • Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma Liver Transpl. 2012 Dec; 18(12):1471-8. . View in PubMed
  • Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection Hepatology. 2012 Nov; 56(5):1651-60. . View in PubMed
  • The option of HBIG-free prophylaxis against recurrent HBV J Hepatol. 2012 May; 56(5):1189-1197. . View in PubMed
  • Multidisciplinary management of hepatocellular carcinoma Clin Gastroenterol Hepatol. 2012 Apr; 10(4):354-62. . View in PubMed
  • Effects of ethnicity and socioeconomic status on survival and severity of fibrosis in liver transplant recipients with hepatitis C virus Liver Transpl. 2012 Apr; 18(4):461-7. . View in PubMed
  • Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality Liver Int. 2012 Jan; 32(1):158-64. . View in PubMed
  • Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus Liver Transpl. 2011 Dec; 17(12):1380-6. . View in PubMed
  • Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era Hepatology. 2011 Oct; 54(4):1313-21. . View in PubMed
  • Individualizing hepatitis B infection prophylaxis in liver transplant recipients J Hepatol. 2011 Sep; 55(3):507-509. . View in PubMed
  • Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men Hepatology. 2011 Aug; 54(2):418-24. . View in PubMed
  • PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus Liver Transpl. 2011 May; 17(5):528-38. . View in PubMed
  • Viral hepatitis and inflammatory bowel disease Inflamm Bowel Dis. 2010 Jun; 16(6):925-32. . View in PubMed
  • Understanding the natural history of chronic HBV and HCV infections J Fam Pract. 2010 Apr; 59(4 Suppl):S17-22. . View in PubMed
  • Non-Markov multistate modeling using time-varying covariates, with application to progression of liver fibrosis due to hepatitis C following liver transplant Int J Biostat. 2010 Feb 20; 6(1):Article 7. . View in PubMed
  • Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women’s Interagency HIV Study (WIHS) AIDS Patient Care STDS. 2009 Nov; 23(11):915-23. . View in PubMed
  • Trends in waiting list registration for liver transplantation for viral hepatitis in the United States Gastroenterology. 2009 Nov; 137(5):1680-6. . View in PubMed
  • Pharmacokinetics of tacrolimus co-administered with adefovir dipivoxil to liver transplant recipients Liver Int. 2009 Sep; 29(8):1178-83. . View in PubMed
  • Management of patients co-infected with HBV and HCV Expert Rev Anti Infect Ther. 2009 Jun; 7(5):549-58. . View in PubMed
  • Benefits and risks of combination therapy for hepatitis B Hepatology. 2009 May; 49(5 Suppl):S122-8. . View in PubMed
  • Hepatitis C virus: a critical appraisal of approaches to therapy Clin Gastroenterol Hepatol. 2009 Apr; 7(4):397-414; quiz 366. . View in PubMed
  • Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C Clin Gastroenterol Hepatol. 2008 Dec; 6(12):1403-11. . View in PubMed
  • Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection Liver Transpl. 2008 Oct; 14(10):1491-7. . View in PubMed
  • Prospective analysis of effector and regulatory CD4+ T cells in chronic HCV patients undergoing combination antiviral therapy J Hepatol. 2008 Sep; 49(3):329-38. . View in PubMed
  • Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis Hepatology. 2008 Sep; 48(3):819-27. . View in PubMed
  • Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection Clin Gastroenterol Hepatol. 2008 May; 6(5):575-83. . View in PubMed
  • Are HIV-infected patients candidates for liver transplantation? J Hepatol. 2008 May; 48(5):697-707.. View in PubMed
  • Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection Liver Transpl. 2008 Apr; 14(4):478-85. . View in PubMed
  • Influence of cannabis use on severity of hepatitis C disease Clin Gastroenterol Hepatol. 2008 Jan; 6(1):69-75. . View in PubMed
  • Management of hepatitis B in liver transplant recipients J Viral Hepat. 2007 Nov; 14 Suppl 1:37-44. . View in PubMed
  • Treating chronic hepatitis B infection in patients who are pregnant or are undergoing immunosuppressive chemotherapy Semin Liver Dis. 2007 Aug; 27 Suppl 1:18-24. . View in PubMed
  • Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results Liver Transpl. 2007 Mar; 13(3):349-60. . View in PubMed
  • Antiviral therapy in liver transplant recipients: is SVR the only endpoint that matters? J Hepatol. 2007 Mar; 46(3):359-61.. View in PubMed
  • Clinical evaluation (Phase I) of a human monoclonal antibody against hepatitis C virus: safety and antiviral activity J Hepatol. 2007 Jan; 46(1):37-44. . View in PubMed
  • Outcomes in hepatitis C virus-infected recipients of living donor vsdeceased donor liver transplantation. Liver Transpl. 2007 Jan; 13(1):122-9. . View in PubMed
  • Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection Hepatology. 2006 Oct; 44(4):925-35. . View in PubMed
  • Treating hepatitis C infection in liver transplant recipients Liver Transpl. 2006 Aug; 12(8):1192-204. . View in PubMed
  • Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1 Gastroenterology. 2006 Aug; 131(2):470-7. . View in PubMed
  • Evidence-based incorporation of serum sodium concentration into MELD Gastroenterology. 2006 May; 130(6):1652-60. . View in PubMed
  • Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation Liver Transpl. 2006 May; 12(5):801-7. . View in PubMed
  • Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data Gastroenterology. 2006 May; 130(6):1636-42. . View in PubMed
  • Management of recurrent hepatitis C in liver transplant recipients Infect Dis Clin North Am. 2006 Mar; 20(1):155-74. . View in PubMed
  • Treatment of recurrent hepatitis C in liver transplant recipients Clin Gastroenterol Hepatol. 2005 Oct; 3(10 Suppl 2):S125-31. . View in PubMed
  • Treatment of recurrent hepatitis C after liver transplantation Clin Liver Dis. 2005 Aug; 9(3):505-23ix. . View in PubMed
  • Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective Liver Transpl. 2005 Jul; 11(7):716-732. . View in PubMed
  • Update on chronic hepatitis C Clin Gastroenterol Hepatol. 2005 Jun; 3(6):507-20. . View in PubMed
  • Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis Clin Gastroenterol Hepatol. 2005 Jan; 3(1):75-84. . View in PubMed
  • Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation Am J Transplant. 2005 Jan; 5(1):118-24. . View in PubMed
  • Antiviral therapy in patients with chronic hepatitis B and cirrhosis Gastroenterol Clin North Am. 2004 Sep; 33(3):629-54x-xi. . View in PubMed
  • Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation Liver Transpl. 2004 Aug; 10(8):975-85. . View in PubMed
  • Hepatitis C virus and lichen planus: a review Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Aug; 98(2):171-83. . View in PubMed
  • Hepatitis B virus genotypes in the United States: results of a nationwide study Gastroenterology. 2003 Aug; 125(2):444-51. . View in PubMed
  • Hepatitis B immune globulin preparations and use in liver transplantation Clin Liver Dis. 2003 Aug; 7(3):537-50. . View in PubMed
  • Burden of liver disease in the United States: summary of a workshop Hepatology. 2002 Jul; 36(1):227-42. . View in PubMed
  • Chronic Hepatitis B Curr Treat Options Gastroenterol. 2001 Dec; 4(6):493-502. . View in PubMed